The investment strengthens Atlantia’s US clinical operations as device manufacturers seek faster, more cost-effective ...

Philips posts 4% Q2 sales growth but relies on EUR 186M tariff refund to boost margins by 4.2 points. Stock falls 9% on China ...

One night in late 1988, Louis Argenta, MD — who had recently been hired as the chairman of the newly formed department of plastic surgery at Wake Forest University — was having trouble sleeping as he ...

Boston Scientific approved a restructuring plan that could reduce expenses by about $500 million a year and lead to the ...

Lindsey Dinneen tackles a critical truth: great ideas fail every day in medtech — not because they lack merit, but because ...

For life sciences executives evaluating digital health portfolios, anatomically informed architectures represent a defensible ...

Guardant Health, creator of the non-invasive blood-based screening test Shield, which detects colorectal cancer, has partnered with actor and Grey’s Anatomy star Patrick Dempsey to raise awareness for ...

The surgical robotics company will wind down operations and liquidate assets after running out of cash to continue ...

Trump imposes 10-12.5% tariffs on 60 trade partners over forced labor claims, covering 99.4% of imports including medical ...

FDA has approved Freenome’s Simple Screen CRC, a blood-based test for colorectal cancer. Abbott Laboratories will exclusively commercialize the test in the U.S. in the fall, according to a release.

DePuy Synthes has acquired Expanding Innovations, a startup specializing in expandable implant technology for spine surgeries ...

As wearable technology evolves from simple step counters to sophisticated health monitoring systems capable of detecting irregular heart rhythms and estimating blood glucose levels, the regulatory ...